Ceres Nanosciences, Manassas, Va, has released the Nanotrap virus capture kit. The kit concentrates whole virus particles from complex biological matrices to produce high-quality material suitable for a range of applications, including multiplex nucleic acid assays, protein assays, and infectivity assays.
Robbie Barbero, PhD, Ceres Nanosciences.
“Many of the samples in the lab have very low concentrations of viruses and we know that every scientist worries about missing out on that next important result,” says Robbie Barbero, PhD, chief business officer at Ceres Nanosciences. “By enabling the use of larger sample volumes without disrupting the downstream workflow, the Nanotrap virus capture kit helps scientists find those low-abundance viruses.”
Ceres has been working with leading infectious disease labs for several years to optimize this technology for virus applications, which has led to several important publications in the field.
Ben Lepene, Ceres Nanosciences.
“We recognize that many research and clinical scientists want to be able to use the Nanotrap technology for their own virus applications,” says Ben Lepene, chief technology officer at Ceres Nanosciences. “With our new configurations of magnetically functionalized and lyophilized Nanotrap virus particles, we now have a product that easily integrates with established downstream workflows.”
Ceres can offer data demonstrating increased nucleic acid yield and compatibility with multiple commercial nucleic acid kits for influenza virus samples as well as an application note demonstrating the use of Nanotrap virus particles to improve the detection of Zika virus in urine samples. Ceres and its collaborators have also demonstrated how the Nanotrap technology can be used to improve nonmolecular assays, including protein assays and infectivity assays.
Ross Dunlap, Ceres Nanosciences.
“We’ve already demonstrated that we can improve detection of respiratory viruses like influenza and RSV, as well as emerging viruses like dengue, chikungunya, and Zika,” says Ross Dunlap, CEO of Ceres Nanosciences. “This is a very versatile product, and I’m eager to learn from our customers what new applications are enabled by it.”
For more information, visit Ceres Nanosciences.
